Carotenoid Nanovector for Efficient Therapeutic Gene Knockdown of Transcription Factor FOXC1 in Liver Cancer

Bioconjugate Chemistry

Volumn 27, Issue 3, 2016, Pages 594-603

  Misra, Santosh K ^a   Ray, Tania ^b   Ostadhossein, Fatemeh ^a   Kim, Bomy ^b   Ray, Partha S ^b   Pan, Dipanjan ^a  

^a United States of America   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLOGY; DISEASES; GENE THERAPY; PIGMENTS; TRANSCRIPTION FACTORS;

CELL NUCLEUS; DENDRITICS; FUNCTIONALIZED; GENE KNOCK DOWN; HEPATOCELLULAR CARCINOMA; LIVER CANCER CELLS; LIVER CANCERS; NANOVECTORS; THERAPEUTIC BENEFITS; THERAPEUTIC GENES;

TRANSCRIPTION;

CAROTENOID; NANOPARTICLE; POLYAMIDOAMINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXC1; FORKHEAD TRANSCRIPTION FACTOR; FOXC1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENE SILENCING; GENETIC TRANSFECTION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; ATOMIC FORCE MICROSCOPY; CARCINOMA, HEPATOCELLULAR; GENE VECTOR; GENETICS; HEP-G2 CELL LINE; LIVER NEOPLASMS; METABOLISM; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY;

CARCINOMA, HEPATOCELLULAR; CAROTENOIDS; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84961761030     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.5b00601     Document Type: Article

References (50)

1. Mears, A. J., Jordan, T., Mirzayans, F., Dubois, S., Kume, T., Parlee, M., Ritch, R., Koop, B., Kuo, W. L., Collins, C., Marshall, J., Gould, D. B., Pearce, W., Carlsson, P., Enerbäck, S., Morissette, J., Bhattacharya, S., Hogan, B., Raymond, V., and Walter, M. A. (1998) Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly Am. J. Hum. Genet. 63, 1316-1328 10.1086/302109
2. Nishimura, D. Y., Swiderski, R. E., Alward, W. L., Searby, C. C., Patil, S. R., Kanis, A. B., Gastier, J. M., Stone, E. M., and Sheffield, V. C. (1998) The forkeahd transcription factor gene FKHL7 is responsible for glaucoma pehotypes which map to 6p25 Nat. Genet. 19, 140-147 10.1038/493
3. Ray, P. S., Wang, J., Qu, Y., Sim, M.-S., Shamonki, J., Bagaria, S. P., Ye, X., Liu, B., Elashoff, D., and Hoon, D. S. et al. 2010, FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer Cancer Res. 70, 3870-3876 10.1158/0008-5472.CAN-09-4120
4. Sizemore, S. T. and Keri, R. A. (2012) The forkhead box transcription factor FOXC1 promotes breast cancer invasion by inducing matrix metalloprotease 7 (MMP7) expression J. Biol. Chem. 287, 24631-24640 10.1074/jbc.M112.375865
5. Wei, L.-X., Zhou, R.-S., Xu, H.-F., Wang, J.-Y., and Yuan, M.-H. (2013) High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients Tumor Biol. 34, 941-946 10.1007/s13277-012-0629-3
6. Xu, Y., Shao, Q. s., Yao, H. b., Jin, Y., Ma, Y. y., and Jia, L. h. (2014) Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients Histopathology 64, 963-970 10.1111/his.12347
7. Wang, L., Gu, F., Liu, C.-Y., Wang, R.-J., Li, J., and Xu, J.-Y. (2013) High level of FOXC1 expression is associated with poor prognosis in pancreatic ductal adenocarcinoma Tumor Biol. 34, 853-858 10.1007/s13277-012-0617-7
8. Xu, Z.-Y., Ding, S.-M., Zhou, L., Xie, H.-Y., Chen, K.-J., Zhang, W., Xing, C.-Y., Guo, H.-J., and Zheng, S.-S. (2012) FOXC1 contributes to microvascular invasion in primary hepatocellular carcinoma via regulating epithelial-mesenchymal transition Int. J. Biol. Sci. 8, 1130 10.7150/ijbs.4769
9. Xia, L., Huang, W., Tian, D., Zhu, H., Qi, X., Chen, Z., Zhang, Y., Hu, H., Fan, D., and Nie, Y. et al. 2013, Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma Hepatology 57, 610-624 10.1002/hep.26029
10. Nagel, S., Meyer, C., Kaufmann, M., Drexler, H. G., and MacLeod, R. A. (2014) Deregulated FOX genes in Hodgkin lymphoma Genes, Chromosomes Cancer 53, 917-933 10.1002/gcc.22204
11. Blonska, M., Zhu, Y., Chuang, H. H., You, M. J., Kunkalla, K., Vega, F., and Lin, X. (2015) Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment Blood 125, 981-991 10.1182/blood-2014-04-568188
12. Nagel, S., Ehrentraut, S., Meyer, C., Kaufmann, M., Drexler, H. G., and MacLeod, R. A. (2015) Repressed BMP signaling reactivates NKL homeobox gene MSX1 in a T-ALL subset Leuk. Lymphoma 56, 480-491 10.3109/10428194.2014.924119
13. Rand, T. A., Ginalski, K., Grishin, N. V., and Wang, X. (2004) Biochemical identification of Argonaute 2 as the sole protein required for RNA-induced silencing complex activity Proc. Natl. Acad. Sci. U. S. A. 101, 14385-14389 10.1073/pnas.0405913101
14. Rand, T. A., Petersen, S., Du, F., and Wang, X. (2005) Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation Cell 123, 621-629 10.1016/j.cell.2005.10.020
15. Hutvagner, G. and Zamore, P. D. (2002) A microRNA in a multiple-turnover RNAi enzyme complex Science 297, 2056-2060 10.1126/science.1073827
16. Bartlett, D. W. and Davis, M. E. (2006) Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging Nucleic Acids Res. 34, 322-333 10.1093/nar/gkj439
17. NIU, X. Y., PENG, Z. L., DUAN, W. Q., Wang, H., and Wang, P. (2006) Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo International Journal of Gynecological Cancer 16, 743-751 10.1111/j.1525-1438.2006.00384.x
18. Halder, J., Kamat, A. A., Landen, C. N., Han, L. Y., Lutgendorf, S. K., Lin, Y. G., Merritt, W. M., Jennings, N. B., Chavez-Reyes, A., and Coleman, R. L. (2006) Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy Clin. Cancer Res. 12, 4916-4924 10.1158/1078-0432.CCR-06-0021
19. Takeshita, F., Minakuchi, Y., Nagahara, S., Honma, K., Sasaki, H., Hirai, K., Teratani, T., Namatame, N., Yamamoto, Y., and Hanai, K. et al. 2005, Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo Proc. Natl. Acad. Sci. U. S. A. 102, 12177-12182 10.1073/pnas.0501753102
20. Frank-Kamenetsky, M., Grefhorst, A., Anderson, N. N., Racie, T. S., Bramlage, B., Akinc, A., Butler, D., Charisse, K., Dorkin, R., and Fan, Y. et al. 2008, Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates Proc. Natl. Acad. Sci. U. S. A. 105, 11915-11920 10.1073/pnas.0805434105
21. Sato, Y., Murase, K., Kato, J., Kobune, M., Sato, T., Kawano, Y., Takimoto, R., Takada, K., Miyanishi, K., and Matsunaga, T. et al. 2008, Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone Nat. Biotechnol. 26, 431-442 10.1038/nbt1396
22. Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., and Lieberman, J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis Nat. Med. 9, 347-351 10.1038/nm828
23. Blaese, M., Blankenstein, T., Brenner, M., Cohen-Haguenauer, O., Gansbacher, B., Russell, S., Sorrentino, B., and Velu, T. (1995) Vectors in cancer therapy: How will they deliver? Cancer gene therapy 2, 291
24. Xie, X. Y., Yang, Y. F., Yang, Y., and Mei, X. G. (2015) Photolabile- caged peptide- conjugated liposomes for siRNA delivery J. Drug Targeting 23, 789-799 10.3109/1061186X.2015.1009077
25. Bochicchio, S., Dalmoro, A., Barba, A. A., Grassi, G., and Lamberti, G. (2015) Liposomes as siRNA Delivery Vectors Curr. Drug Metab. 15, 882-892 10.2174/1389200216666150206124913
26. Hattori, Y., Nakamura, A., Arai, S., Kawano, K., Maitani, Y., and Yonemochi, E. (2015) siRNA delivery to lung- metastasized tumor by systemic injection with cationic liposomes J. Liposome Res. 25, 279-286 10.3109/08982104.2014.992024
27. Lytton-Jean, A. K. R., Langer, R., and Anderson, D. G. (2011) Five Years of siRNA Delivery: Spotlight on Gold Nanoparticles Small 7, 1932-1937 10.1002/smll.201100761
28. Elbakry, A., Zaky, A., Liebl, R., Rachel, R., Goepferich, A., and Breunig, M. (2009) Layer- by- Layer Assembled Gold Nanoparticles for siRNA Delivery Nano Lett. 9, 2059-2064 10.1021/nl9003865
29. Kim, S. T., Chompoosor, A., Yeh, Y.-C., Agasti, S. S., Solfiell, D. J., and Rotello, V. M. (2012) Dendronized gold nanoparticles for siRNA delivery Small 8, 3253-6 10.1002/smll.201201141
30. Blackburn, W. H., Dickerson, E. B., Smith, M. H., McDonald, J. F., and Lyon, L. A. (2009) Peptide- Functionalized Nanogels for Targeted siRNA Delivery Bioconjugate Chem. 20, 960-968 10.1021/bc800547c
31. Ashley, C. E., Carnes, E. C., Epler, K. E., Padilla, D. P., Phillips, G. K., Castillo, R. E., Wilkinson, D. C., Wilkinson, B. S., Burgard, C. A., and Kalinich, R. M. et al. 2012, Delivery of Small Interfering RNA by Peptide- Targeted Mesoporous Silica Nanoparticle- Supported Lipid Bilayers ACS Nano 6, 2174-2188 10.1021/nn204102q
32. Singha, K., Namgung, R., and Kim, W. J. (2011) Polymers in small- interfering RNA delivery Nucleic Acid Ther. 21, 133-147 10.1089/nat.2011.0293
33. Zhao, J. and Feng, S.-S. (2015) Nanocarriers for delivery of siRNA and co- delivery of siRNA and other therapeutic agents Nanomedicine (London, U. K.) 10, 2199-2228 10.2217/nnm.15.61
34. Xiao, S., Castro, R., Rodrigues, J., Shi, X., and Tomás, H. (2015) PAMAM Dendrimer/pDNA Functionalized-Magnetic Iron Oxide Nanoparticles for Gene Delivery J. Biomed. Nanotechnol. 11, 1370-1384 10.1166/jbn.2015.2101
35. Kong, L., Alves, C. S., Hou, W., Qiu, J., Möhwald, H., Tomás, H., and Shi, X. (2015) RGD Peptide-Modified Dendrimer-Entrapped Gold Nanoparticles Enable Highly Efficient and Specific Gene Delivery to Stem Cells ACS Appl. Mater. Interfaces 7, 4833-4843 10.1021/am508760w
36. Yang, J., Zhang, Q., Chang, H., and Cheng, Y. (2015) Surface-Engineered Dendrimers in Gene Delivery Chem. Rev. 115, 5274-5300 10.1021/cr500542t
37. Khan, O. F., Zaia, E. W., Jhunjhunwala, S., Xue, W., Cai, W., Yun, D. S., Barnes, C. M., Dahlman, J. E., Dong, Y., and Pelet, J. M. et al. 2015, Dendrimer-inspired nanomaterials for the in vivo delivery of siRNA to lung vasculature Nano Lett. 15, 3008-3016 10.1021/nl5048972
38. Khan, O. F., Zaia, E. W., Yin, H., Bogorad, R. L., Pelet, J. M., Webber, M. J., Zhuang, I., Dahlman, J. E., Langer, R., and Anderson, D. G. (2014) Ionizable Amphiphilic Dendrimer Based Nanomaterials with AlkylChainSubstituted Amines for Tunable siRNA Delivery to the Liver Endothelium In Vivo Angew. Chem. 126, 14625-14629 10.1002/ange.201408221
39. Posocco, P., Liu, X., Laurini, E., Marson, D., Chen, C., Liu, C., Fermeglia, M., Rocchi, P., Pricl, S., and Peng, L. (2013) Impact of siRNA overhangs for dendrimer-mediated siRNA delivery and gene silencing Mol. Pharmaceutics 10, 3262-3273 10.1021/mp400329g
40. Junghans, A., Sies, H., and Stahl, W. (2000) Carotenoid-containing unilamellar liposomes loaded with glutathione: A model to study hydrophobic-hydrophilic antioxidant interaction Free Radical Res. 33, 801-808 10.1080/10715760000301321
41. McNulty, H., Jacob, R. F., and Mason, R. P. (2008) Biologic activity of carotenoids related to distinct membrane physicochemical interactions Am. J. Cardiol. 101, S20-S29 10.1016/j.amjcard.2008.02.004
42. McNulty, H. P., Byun, J., Lockwood, S. F., Jacob, R. F., and Mason, R. P. (2007) Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis Biochim. Biophys. Acta, Biomembr. 1768, 167-174 10.1016/j.bbamem.2006.09.010
43. Subczynski, W. K., Wisniewska, A., and Widomska, J. (2010) Location of macular xanthophylls in the most vulnerable regions of photoreceptor outer-segment membranes Arch. Biochem. Biophys. 504, 61-66 10.1016/j.abb.2010.05.015
44. Hidalgo, P., Strzalka, K., and Kostecka-Gugala, A. (2002) Comparative X-ray studies on the interaction of carotenoids with a model phosphatidylcholine membrane Z. Naturforsch., C: J. Biosci. 57, 129-134 10.1515/znc-2002-1-222
45. Scaggiante, B., Kazemi, M., Pozzato, G., Dapas, B., Farra, R., Grassi, M., Zanconati, F., and Grassi, G. (2014) Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials World J. Gastroenterol. 20, 1268-1288 10.3748/wjg.v20.i5.1268
46. Sima, N., Cheng, X., Ye, F., Ma, D., Xie, X., and Lü, W. (2013) The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC PLoS One 8, e74594 10.1371/journal.pone.0074594
47. Lane, C. F. (1975) Sodium cyanoborohydride-A highly selective reducing agent for organic functional groups Synthesis 1975, 135-146 10.1055/s-1975-23685
48. Yang, Y., Nunes, F. A., Berencsi, K., Gönczöl, E., Engelhardt, J. F., and Wilson, J. M. (1994) Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis Nat. Genet. 7, 362-369 10.1038/ng0794-362
49. Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., and Wilson, J. M. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy Proc. Natl. Acad. Sci. U. S. A. 91, 4407-4411 10.1073/pnas.91.10.4407
50. Knowles, M. R., Hohneker, K. W., Zhou, Z., Olsen, J. C., Noah, T. L., Hu, P. C., Leigh, M. W., Engelhardt, J. F., Edwards, L. J., and Jones, K. R. et al. 1995, A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis N. Engl. J. Med. 333, 823-831 10.1056/NEJM199509283331302